Tag: maternal vaccination
-
Low RSV Maternal Vaccination Uptake in Japan: New Survey Findings
Overview: Why maternal RSV vaccination matters Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections in young children. Vaccinating pregnant women can transfer protective antibodies to the fetus, helping newborns fight RSV in their first months of life. This protective strategy—administered during pregnancy—has the potential to reduce hospitalizations and severe disease…
-
Low Uptake of Maternal RSV Vaccination in Japan: What the Survey Reveals
Overview: Why Maternal RSV Vaccination Matters RSV, or respiratory syncytial virus, is a leading cause of acute lower respiratory infections in young children. Administering RSV vaccines to pregnant women enables antibodies to transfer through the placenta, offering newborns protection during the first months of life. This strategy has the potential to reduce hospitalizations and severe…
-
RSVpreF maternal vaccination lowers infant hospitalizations
Real-world evidence confirms the protective effect of RSVpreF during pregnancy New real-world data reinforce the importance of maternal vaccination against respiratory syncytial virus (RSV) using the pre-fusion F (RSVpreF) protein. In recent analyses, infants whose mothers received the RSVpreF vaccine during pregnancy showed a substantial reduction in hospitalizations due to RSV infection during the first…
-
Maternal RSVpreF Vaccination Lowers Infant Hospitalization Risk
Overview: Maternal RSVpreF vaccination and infant protection New real-world evidence is reinforcing the protective effect of maternal vaccination against respiratory syncytial virus (RSV) in early infancy. Data emerging from observational studies suggest that vaccinating pregnant people with the RSV pre-fusion F (RSVpreF) vaccine is associated with a substantial reduction in hospitalizations among young infants, particularly…
-
What Parents Need to Know About RSV Immunization for Infants
Understanding RSV and Why Immunization Matters Respiratory syncytial virus (RSV) is a common illness that can cause serious breathing problems in young infants, especially those born prematurely or with certain health conditions. While many babies recover at home with supportive care, RSV can lead to dangerous complications and hospitalizations in a small but important group.…
-
RSV on Track Hit Worst on Record in WA Despite Immunisation
WA Faces a Record RSV Year Despite Strong Immunisation Uptake Western Australia is approaching a historically high level of respiratory syncytial virus (RSV) activity. Latest Department of Health data show 11,551 RSV cases reported by Monday, just 104 away from the record set in 2022. While not eclipsing that peak yet, the trajectory suggests a…
-
Australia’s RSV immunisation rollout: thousands protected, but gaps remain
New era for infant RSV protection in Australia In 2025, Australia introduced free access to RSV immunisations for all infants, a landmark step in protecting the youngest, most vulnerable Australians from severe respiratory disease. Early indicators are encouraging: sentinel hospital data suggest a substantial drop in RSV-related hospitalisations and intensive care admissions during the peak…
-
Infant RSV immunisation: thousands protected, but gaps remain
Australia’s RSV protection milestone: free infant immunisation for all babies In 2025, Australia rolled out free access to RSV immunisations for all infants, marking a watershed moment in the fight against a virus that routinely causes hospitalisations among young children. Early indicators suggest the program has saved lives and reduced the burden on hospitals, but…